We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+15.89%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$280M
AUM Growth
+$20.1M
Cap. Flow
-$12.5M
Cap. Flow %
-4.46%
Top 10 Hldgs %
29.94%
Holding
74
New
13
Increased
17
Reduced
27
Closed
12

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$4.68M
2
ESRX
Express Scripts Holding Company
ESRX
+$3.86M
3
COR icon
Cencora
COR
+$3.68M
4
SYK icon
Stryker
SYK
+$3.41M
5
MOH icon
Molina Healthcare
MOH
+$3.19M

Sector Composition

Rank Sector Weight
1 Healthcare 91.22%
2 Financials 2.53%
3 Energy 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
26
AstraZeneca
AZN
$246B
$4.95M 1.77%
62,500
-12,500
-17% -$945K
TMO icon
27
Thermo Fisher Scientific
TMO
$224B
$4.88M 1.74%
20,000
-10,000
-33% -$2.3M
GWPH
28
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.75M 1.7%
+27,500
New +$3.97M
CELG
29
DELISTED
Celgene Corp
CELG
$4.47M 1.6%
50,000
+20,000
+67% +$1.77M
BHC icon
30
Bausch Health
BHC
$2.33B
$4.36M 1.56%
170,000
+30,000
+21% +$687K
DGX icon
31
Quest Diagnostics
DGX
$26.2B
$4.32M 1.54%
40,000
+10,000
+33% +$1.1M
TEVA icon
32
Teva Pharmaceuticals
TEVA
$42.5B
$4.31M 1.54%
200,000
-85,000
-30% -$1.97M
WMGI
33
DELISTED
Wright Medical Group Inc
WMGI
$4.06M 1.45%
140,000
+55,100
+65% +$1.48M
SRPT icon
34
Sarepta Therapeutics
SRPT
$1.92B
$4.04M 1.44%
25,000
-5,000
-17% -$684K
LHCG
35
DELISTED
LHC Group LLC
LHCG
$3.6M 1.29%
35,000
VTRS icon
36
Viatris
VTRS
$18.7B
$3.48M 1.24%
95,000
-65,000
-41% -$2.44M
ALXN
37
DELISTED
Alexion Pharmaceuticals
ALXN
$3.48M 1.24%
25,000
-5,000
-17% -$627K
COR icon
38
Cencora
COR
$63.7B
$3.46M 1.23%
37,500
-42,500
-53% -$3.68M
CAH icon
39
Cardinal Health
CAH
$56.3B
$3.24M 1.16%
+60,000
New +$3.07M
QGEN icon
40
Qiagen
QGEN
$8.81B
$3.22M 1.15%
80,160
-28,291
-26% -$1.13M
MCK icon
41
McKesson
MCK
$105B
$2.98M 1.07%
22,500
-12,500
-36% -$1.63M
DXCM icon
42
DexCom
DXCM
$33.8B
$2.86M 1.02%
80,000
+36,400
+83% +$1.13M
INCY icon
43
Incyte
INCY
$24.5B
$2.76M 0.99%
40,000
-45,000
-53% -$3.09M
BPMC
44
DELISTED
Blueprint Medicines
BPMC
$2.73M 0.98%
+35,000
New +$2.43M
LH icon
45
Labcorp
LH
$26.1B
$2.6M 0.93%
+17,460
New +$2.66M
LOXO
46
DELISTED
Loxo Oncology, Inc
LOXO
$2.56M 0.91%
15,000
-5,000
-25% -$840K
THC icon
47
Tenet Healthcare
THC
$20.9B
$2.42M 0.86%
+85,000
New +$2.81M
TDOC icon
48
Teladoc Health
TDOC
$1.24B
$2.36M 0.84%
+27,360
New +$1.95M
HAE icon
49
Haemonetics
HAE
$3.97B
$2.29M 0.82%
+20,000
New +$2.07M
EVHC
50
DELISTED
Envision Healthcare Holdings Inc
EVHC
$2.06M 0.73%
45,000

Similar funds

Sivik Global Healthcare's Q3 2018 Portfolio in Review

As of Q3 2018, Sivik Global Healthcare held 74 positions worth $280M, up 7.7% from $260M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Sivik Global Healthcare withdrew a net $12.5M in Q3 2018, closing 12 positions and reducing 27 holdings. Its most notable exit was Zoetis, an estimated $4.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 94% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in HCA Healthcare worth $7.65M.

  • Sivik Global Healthcare's largest Q3 2018 buy was HCA Healthcare: 55,000 shares worth $7.65M.
  • Sivik Global Healthcare added most to Cigna in Q3 2018, an estimated $2.78M increase.
  • Sivik Global Healthcare's biggest Q3 2018 reduction was Cencora, cutting an estimated $3.68M.
  • Sivik Global Healthcare fully exited Zoetis in Q3 2018, selling an estimated $4.68M.
  • Sivik Global Healthcare's ten largest holdings make up 30% of its $280M portfolio in Q3 2018.
  • Sivik Global Healthcare opened 13 new positions and closed 12 in Q3 2018.
  • Sivik Global Healthcare's portfolio value rose 7.7% quarter-over-quarter to $280M.

Based on Sivik Global Healthcare's 13F filing for Q3 2018, filed 13 Nov 2018.